VM:CA:CDX-Voyageur Minerals Ltd. (CAD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic | TSX Venture Exchange

Last Closing

USD 0.08

Change

0.00 (0.00)%

Market Cap

USD 0.28M

Volume

0.19M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Voyageur Minerals Ltd develops near term cash flow on barite projects in British Columbia, Canada and explores and develops lithium brine projects in Utah USA.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
RX:CA Biosyent Inc.

+0.80 (+8.69%)

USD 0.11B
ZYUS:CA ZYUS Life Sciences Corporation

N/A

USD 0.07B
LOVE:CA Cannara Biotech Inc

N/A

USD 0.06B
SBBC:CA Simply Better Brands Corp

+0.03 (+4.17%)

USD 0.06B
LSL:CA LSL Pharma Group Inc.

-0.01 (-2.04%)

USD 0.05B
DB:CA Decibel Cannabis Company Inc

N/A

USD 0.03B
ROMJ:CA Rubicon Organics Inc

-0.01 (-2.50%)

USD 0.03B
PCLO:CA Pharmacielo Ltd

N/A

USD 0.03B
ELXR:CA Elixxer Ltd

N/A

USD 0.01B
MPH:CA Medicure Inc

N/A

USD 0.01B

ETFs Containing VM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange (TSX Venture Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.67% 65% D 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.67% 65% D 60% D-
Trailing 12 Months  
Capital Gain 14.29% 76% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.29% 76% C+ 76% C+
Trailing 5 Years  
Capital Gain 14.29% 90% A- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.29% 90% A- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.23% 70% C- 59% D-
Dividend Return 7.23% 70% C- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.77% 35% F 43% F
Risk Adjusted Return 12.10% 85% B 59% D-
Market Capitalization 0.28M 52% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector